Literature DB >> 31073534

Precision Medicine.

Michael R Kosorok1, Eric B Laber2.   

Abstract

Precision medicine seeks to maximize the quality of healthcare by individualizing the healthcare process to the uniquely evolving health status of each patient. This endeavor spans a broad range of scientific areas including drug discovery, genetics/genomics, health communication, and causal inference all in support of evidence-based, i.e., data-driven, decision making. Precision medicine is formalized as a treatment regime which comprises a sequence of decision rules, one per decision point, which map up-to-date patient information to a recommended action. The potential actions could be the selection of which drug to use, the selection of dose, timing of administration, specific diet or exercise recommendation, or other aspects of treatment or care. Statistics research in precision medicine is broadly focused on methodological development for estimation of and inference for treatment regimes which maximize some cumulative clinical outcome. In this review, we provide an overview of this vibrant area of research and present important and emerging challenges.

Entities:  

Keywords:  data-driven decision science; dynamic treatment regimes; machine learning; patient heterogeneity; statistical inference

Year:  2019        PMID: 31073534      PMCID: PMC6502478          DOI: 10.1146/annurev-statistics-030718-105251

Source DB:  PubMed          Journal:  Annu Rev Stat Appl        ISSN: 2326-8298            Impact factor:   5.810


  84 in total

1.  Statistics versus statistical science in the regulatory process.

Authors:  N T Longford; J A Nelder
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

4.  Dynamic treatment regimes: practical design considerations.

Authors:  Philip W Lavori; Ree Dawson
Journal:  Clin Trials       Date:  2004-02       Impact factor: 2.486

5.  A Generalization Error for Q-Learning.

Authors:  Susan A Murphy
Journal:  J Mach Learn Res       Date:  2005-07       Impact factor: 3.654

6.  Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring.

Authors:  Peter F Thall; Leiko H Wooten; Christopher J Logothetis; Randall E Millikan; Nizar M Tannir
Journal:  Stat Med       Date:  2007-11-20       Impact factor: 2.373

7.  Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules.

Authors:  Oliver Bembom; Mark J van der Laan
Journal:  Stat Med       Date:  2008-08-30       Impact factor: 2.373

8.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Authors:  Richard L Kravitz; Naihua Duan; Joel Braslow
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 9.  Inference for non-regular parameters in optimal dynamic treatment regimes.

Authors:  Bibhas Chakraborty; Susan Murphy; Victor Strecher
Journal:  Stat Methods Med Res       Date:  2009-07-16       Impact factor: 3.021

10.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

View more
  22 in total

1.  Personalized treatment selection using data from crossover designs with carry-over effects.

Authors:  Chathura Siriwardhana; K B Kulasekera; Somnath Datta
Journal:  Stat Med       Date:  2019-10-21       Impact factor: 2.373

2.  A latent class analysis of resilience and its relationship with depressive symptoms in the parents of children with cancer.

Authors:  Yuanhui Luo; Anni Wang; Yue Zeng; Jingping Zhang
Journal:  Support Care Cancer       Date:  2022-01-31       Impact factor: 3.603

3.  A sparse additive model for treatment effect-modifier selection.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.279

4.  Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data.

Authors:  Andreas D Meid; Carmen Ruff; Lucas Wirbka; Felicitas Stoll; Hanna M Seidling; Andreas Groll; Walter E Haefeli
Journal:  Clin Epidemiol       Date:  2020-11-02       Impact factor: 4.790

5.  Constructing dynamic treatment regimes with shared parameters for censored data.

Authors:  Ying-Qi Zhao; Ruoqing Zhu; Guanhua Chen; Yingye Zheng
Journal:  Stat Med       Date:  2020-01-17       Impact factor: 2.373

6.  The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.

Authors:  Anastasia Ivanova; Elliot Israel; Lisa M LaVange; Michael C Peters; Loren C Denlinger; Wendy C Moore; Leonard B Bacharier; M Alison Marquis; Nathan M Gotman; Michael R Kosorok; Chalmer Tomlinson; David T Mauger; Steve N Georas; Rosalind J Wright; Patricia Noel; Gary L Rosner; Praveen Akuthota; Dean Billheimer; Eugene R Bleecker; Juan Carlos Cardet; Mario Castro; Emily A DiMango; Serpil C Erzurum; John V Fahy; Merritt L Fajt; Benjamin M Gaston; Fernando Holguin; Sonia Jain; Nicholas J Kenyon; Jerry A Krishnan; Monica Kraft; Rajesh Kumar; Mark C Liu; Ngoc P Ly; James N Moy; Wanda Phipatanakul; Kristie Ross; Lewis J Smith; Stanley J Szefler; W Gerald Teague; Michael E Wechsler; Sally E Wenzel; Steven R White
Journal:  J Biopharm Stat       Date:  2020-09-17       Impact factor: 1.051

7.  A semiparametric instrumental variable approach to optimal treatment regimes under endogeneity.

Authors:  Yifan Cui; Eric Tchetgen Tchetgen
Journal:  J Am Stat Assoc       Date:  2020-08-04       Impact factor: 5.033

8.  Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma.

Authors:  Alind Gupta; Paul Arora; Darren Brenner; Jacqueline Vanderpuye-Orgle; Devon J Boyne; Mark Edmondson-Jones; Elena Parkhomenko; Warren Stevens; Shaan Dudani; Daniel Y C Heng; Samuel Wagner; John Borrill; Elise Wu
Journal:  JCO Clin Cancer Inform       Date:  2021-03

9.  Beyond Two Cultures: Cultural Infrastructure for Data-driven Decision Support.

Authors:  Nikki L B Freeman; John Sperger; Helal El-Zaatari; Anna R Kahkoska; Minxin Lu; Michael Valancius; Arti V Virkud; Tarek M Zikry; Michael R Kosorok
Journal:  Obs Stud       Date:  2021-07

10.  Editorial: Precision Medicine in Veterinary Oncology.

Authors:  Carlos Eduardo Fonseca-Alves; Chiara Palmieri; Maria Lucia Zaidan Dagli; Renée Laufer-Amorim
Journal:  Front Vet Sci       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.